Heartcore Enterprises, Inc. (HTCR) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on July 11, 2025, by Heartcore Enterprises, Inc., a Delaware corporation headquartered in Tokyo, Japan. The filing addresses the Company's status regarding Nasdaq Capital Market listing compliance and details recent financing arrangements.
Key Financial Metrics and Liquidity
The filing does not provide specific revenue, profit, cash flow, or margin figures for the reporting period. However, it discloses the following financial context:
- Listing Deficiency: The Company failed to meet the Nasdaq Listing Rule 5550(b) minimum stockholders' equity requirement of $2,500,000 as of May 23, 2025.
- Financing Transactions:
- Equity Line of Credit (ELOC): An agreement with Crom Structured Opportunities Fund I, LP allows the Company to direct the purchase of up to $25,000,000 in common stock.
- Private Placement: The Company issued 2,000 shares of Series A Convertible Preferred Stock at $1,000 per share, raising $2,000,000 in aggregate proceeds.
- Commitment Shares: 750,000 shares of common stock were issued to the Investor for no additional consideration at closing.
Material Changes and Compliance Status
On July 11, 2025, the Nasdaq Staff granted the Company an extension to regain compliance with the Minimum Stockholders' Equity Requirement. The Company must complete the Financing Transactions and evidence compliance by September 30, 2025. There was no immediate effect on the listing or trading of the Company's common stock (HTCR) on the Nasdaq Capital Market.
Outlook, Risks, and Management Commentary
Management notes that the Company obtained stockholder approval on June 30, 2025, to issue shares in excess of 19.99% of outstanding common stock under the ELOC. However, the issuance of Advance Shares is contingent upon the SEC declaring a registration statement effective. An Information Statement on Schedule 14C regarding the 20% Issuance will be filed and mailed to stockholders, with effectiveness no earlier than 20 calendar days after mailing.
Risks: The filing explicitly states there can be no assurance that the Company will be able to regain compliance with the Minimum Stockholders' Equity Requirement, even if it maintains compliance with other listing requirements.
Key Facts for Investor Verification
- Verify the effectiveness of the SEC registration statement required for the resale of Conversion Shares and SPA Commitment Shares.
- Monitor the Company's progress in completing the Financing Transactions by the September 30, 2025 deadline.
- Confirm the filing and mailing date of the Schedule 14C Information Statement to determine the earliest possible effective date for the 20% Issuance.
- Assess the Company's ability to raise the necessary capital to meet the $2,500,000 minimum stockholders' equity threshold.